SWS Medical to showcase cutting-edge blood purification technology at Arab Health 2025

SWS Medical is set to participate in the Arab Health 2025 held from January 27 to 30 in Dubai, the United Arab Emirates (UAE), marking the company's sixth consecutive year at the event.

"Arab Health 2025 is a pivotal event for us," said Gao Guangyong, chairman of SWS Medical. "Our vision extends beyond borders, and our participation in this event is in line with our international expansion strategy, allowing us to continue to forge partnerships and shape a brighter healthcare future."

At the Arab Health 2025, SWS Medical will present its latest innovations in blood purification technologies, highlighting its advancements in dialysis and critically-ill solutions. The company has developed a comprehensive full industry chain in the blood purification sector, from R&D to manufacturing and distribution. This integrated approach ensures that SWS Medical can provide high-quality, reliable, and cutting-edge products to healthcare providers worldwide.

For over two decades, SWS Hemodialysis Care Co., Ltd., a wholly-owned subsidiary of SWS Medical, has cemented itself as a key player in the blood purification sector. Its products have been exported to nearly 100 countries around the world, and the company holds as many as 200 authorized patents. This success is a testament to SWS Medical's dedication to innovation and its ability to meet the evolving needs of the global healthcare market.

As the largest healthcare exhibition in the Middle East, Arab Health serves as a vital platform for industry professionals to explore the latest medical technologies and innovations. As an epitome of Chinese medical enterprises going overseas, SWS's presence at the Arab Health will not only showcase its cutting-edge technology but also cement its position as a leading player in the global blood purification industry.